Novel Liposomal Formulation for Targeted Gene Delivery

[1]  E. Stachowiak,et al.  Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Sinn,et al.  Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production , 2005, Gene Therapy.

[3]  H. Lipps,et al.  Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.

[4]  L. Jeffs,et al.  A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA , 2005, Pharmaceutical Research.

[5]  O. Katare,et al.  Liposomal drug delivery systems--clinical applications. , 2005, Acta pharmaceutica.

[6]  R. Nixon.  Prion-associated Increases in Src-family Kinases* , 2005, Journal of Biological Chemistry.

[7]  H. Lee,et al.  Immunoliposomes carrying plasmid DNA: preparation and characterization , 2004, Archives of pharmacal research.

[8]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[9]  P. Lowenstein,et al.  Recent advances in the pharmacology of neurological gene therapy. , 2004, Current opinion in pharmacology.

[10]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[11]  N. Chirmule,et al.  Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy , 2003, Gene Therapy.

[12]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[13]  S S Gambhir,et al.  Optical imaging of transferrin targeted PEI/DNA complexes in living subjects , 2003, Gene Therapy.

[14]  X. Breakefield,et al.  Viral vectors for gene delivery to the nervous system , 2003, Nature Reviews Neuroscience.

[15]  F. Dosio,et al.  From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy , 2003, Tumori.

[16]  D F P Larkin,et al.  Antibody targeted gene transfer to endothelium , 2003, The journal of gene medicine.

[17]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[18]  N. Templeton.  Liposomal delivery of nucleic acids in vivo , 2002 .

[19]  W. Pardridge,et al.  Receptor‐mediated delivery of an antisense gene to human brain cancer cells , 2002, The journal of gene medicine.

[20]  W. Pardridge,et al.  Brain-specific expression of an exogenous gene after i.v. administration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Wilson,et al.  Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  J. Bloch,et al.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.

[23]  S. M. Sullivan,et al.  Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. , 2000, Biochimica et biophysica acta.

[24]  Maruyama,et al.  Possibility of active targeting to tumor tissues with liposomes. , 1999, Advanced drug delivery reviews.

[25]  J. Hoh,et al.  Ethanol-induced structural transitions of DNA on mica. , 1999, Nucleic acids research.

[26]  W. Pardridge,et al.  Ten nucleotide cis element in the 3'-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. , 1998, Brain research. Molecular brain research.

[27]  P. Cullis,et al.  Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.

[28]  P. Luisi,et al.  Entrapment of nucleic acids in liposomes. , 1997, Biochimica et biophysica acta.

[29]  Kaplitt,et al.  Viral Vectors for Gene Delivery and Expression in the CNS , 1996, Methods.

[30]  J. Huwyler,et al.  Brain drug delivery of small molecules using immunoliposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Godowski,et al.  Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. , 1996, Journal of pharmaceutical sciences.

[32]  M. Stuart,et al.  Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. , 1995, Biochimica et biophysica acta.

[33]  D. Liggitt,et al.  Systemic gene expression after intravenous DNA delivery into adult mice. , 1993, Science.

[34]  D. Mash,et al.  Characterization and Distribution of Transferrin Receptors in the Rat Brain , 1990, Journal of neurochemistry.

[35]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[36]  H. Kingdon,et al.  A two-phase linear regression model for biologic half-life data. , 1990, The Journal of laboratory and clinical medicine.

[37]  Z. Jonak,et al.  Gene transfer from targeted liposomes to specific lymphoid cells by electroporation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Huang,et al.  pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Nicolau,et al.  Intracellular fate of liposome-encapsulated DNA in mouse liver. Analysis using electron microscope autoradiography and subcellular fractionation. , 1985, Biochimica et biophysica acta.

[40]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[41]  L. Leserman,et al.  Cell-specific drug transfer from liposomes bearing monoclonal antibodies , 1981, Nature.

[42]  J. Huwyler,et al.  Drug transport to brain with targeted liposomes , 2005 .

[43]  F. Calon,et al.  Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.

[44]  Yechezkel Barenholz,et al.  Pharmacokinetics of Pegylated Liposomal Doxorubicin , 2003, Clinical pharmacokinetics.

[45]  W. Pardridge,et al.  Noninvasive gene targeting to the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Trotta,et al.  PREPARATION AND CHARACTERIZATION OF , 1996 .

[47]  M. Hashida,et al.  In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. , 1995, Journal of drug targeting.